Please login to the form below

Not currently logged in
Email:
Password:

obintuzumab

This page shows the latest obintuzumab news and features for those working in and with pharma, biotech and healthcare.

Roche signs biologics partnership with Samsung

Roche signs biologics partnership with Samsung

In addition, the company has 39 investigational biologic medicines in its pipeline, the most advanced of which is chronic lymphocytic leukaemia candidate obintuzumab.

Latest news

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...
APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

Infographics